Cephalexin NDC 70518-4511

Product information

Brand name (proprietary)

Cephalexin

Generic name (nonproprietary)

cephalexin

Active ingredients

Cephalexin — 250 mg/5mL

Dosage form

For suspension

Route

Oral

Labeler

REMEDYREPACK INC.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 210221

Marketing start

Oct 28, 2025

Listing expires

Dec 31, 2027

Other FDA classes

Cephalosporins (Chemical structure)

Identifiers

Product ID 70518-4511_5b870337-c133-dd79-e063-6394a90a03efSPL ID 5b870337-c133-dd79-e063-6394a90a03ef

Pharmacologic class

Cephalosporin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518451100 followed by a unit qualifier and the quantity Copy

Package 70518-4511-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 210221

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.